Mohammad Abdeh-Zadeh, the head of the Health Economy Commission of the Tehran Chamber of Commerce, announced that the severe drug shortage continues in the last quarter of the year, and producers and importers of drugs are daily queuing to address import issues at the Central Bank and the Ministry of Health.
Tehran Chamber of Commerce Health Economy Commission: Severe Drug Shortage Continues in the Last Quarter of the Year
The head of the Health Economy Commission in Tehran has reported that a severe drug shortage is persisting as the year comes to a close. Drug producers and importers are facing ongoing challenges with imports, necessitating their frequent visits to government authorities. This situation highlights significant issues in Iran's healthcare supply chain.
👥 Key Players
📰 What Happened
The head of the Health Economy Commission reported a continuing severe drug shortage in Iran, with producers and importers struggling to resolve import issues at key government offices.
- Drug producers and importers are facing daily challenges in securing necessary imports.
- The shortage is particularly acute as the year approaches its end, indicating systemic issues in the healthcare supply chain.
💡 Why It Matters
📚 Background
Iran has faced significant challenges in its healthcare system, particularly due to economic sanctions that limit access to necessary medical supplies and pharmaceuticals.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%